All partnering requests
Private Company
High-throughput assays for wound healing and tissue regeneration
  • Background
  • What we're looking for
  • What we can offer you
  • Q&A
Have questions about this request?
Get them answered by the team at the company.
Background

We are a global leader in consumer health and wellness, developing science-based solutions that support the body’s natural repair processes. Wound healing and tissue regeneration involve coordinated cellular processes including proliferation, migration, extracellular matrix remodeling, and inflammatory signaling. Screening compounds that influence these processes requires experimental systems capable of capturing key biological responses while allowing efficient testing of multiple candidates. 

 

Currently, early-stage screening for compounds affecting wound healing is often performed using in vitro assays that can be labor-intensive, limited in throughput, and may not fully capture the complexity of tissue regeneration processes such as extracellular matrix remodeling, coordinated cell migration, or multicellular interactions. 

 

High-throughput experimental platforms suitable for evaluating multiple compounds that may influence the aforementioned cellular processes would enable more efficient identification and characterization of candidates that promote regenerative responses across multiple biological endpoints.

What we're looking for

We are seeking high-throughput in vitro platforms capable of screening compounds for activity related to wound healing, tissue repair, and cellular regeneration.. We are particularly interested in collaborating with contract research organizations (CROs) with expertisein dermatology, epithelial biology, fibroblast biology, or regenerative biology assays.

Solutions of interest include:
  • 3D skin or epithelial tissue models compatible with screening
  • Assays measuring extracellular matrix (ECM) production or remodeling
  • Automated cell migration or proliferation assays
  • High-content imaging platforms for regeneration endpoints
  • High-throughput scratch or wound-closure assays
  • Multiplexed screening platforms for compound libraries
Our must-have requirements are:
  • Enables scalable testing of multiple compounds and concentrations in vitro
  • Potential to generate quantitative readouts relevant to tissue repair processes
Our nice-to-have's are:
  • Captures cellular behaviors such as migration, proliferation, matrix production, or related regenerative responses
Acceptable technology readiness levels (TRL):
Levels 2-9
What we can offer you
Eligible partnership models:
Sponsored research
Benefits:
Sponsored Research
Funding available for sponsored research projects conducted by expert CRO partners. Scope may expand to additional studies based on initial results/development. The scope of work and budget will be negotiated based on the proposed approach, project duration, and expected impact. For similar proof-of-concept projects, budgets have typically ranged from $50,000 to $120,000 for a 6–12 month effort.
Expertise
Partners will interact with a project lead to mutually develop a project plan and engage in regular meetings to ensure success. Partners will have access to internal team/experts as appropriate.
Q&A with the company

The Q&A is now closed.

Sort by:
Q.
Hello we have ex vivo skin models for throughput testing of wound responses.
9
A.
Great! Please submit a proposal!
Team Member, Reviewer, Private Company
April 20, 2026
Is this response helpful?
0
0
Q.
We have a microfluidic organ-on-chip combined with a bioreactor, recently under developing. It has different stage of screening (pH, degradation & biocompat...). It's supposed to be used for our drug carrier screening.
4
A.
sounds very interesting, please submit a proposal!
Team Member, Reviewer, Private Company
April 20, 2026
Is this response helpful?
0
0
Q.
We have an advanced automation platform for organoid production and analysis, and are collaborating to generate scalable, standardised skin organoid models - would this be of interest?
4
A.
Potentially; please submit a proposal!
Team Member, Reviewer, Private Company
April 20, 2026
Is this response helpful?
0
0
Q.
We created a nanodrug that ensures effective healing of wounds (open, post-operative, gunshot), as well as complete non-surgical restoration of skin tissue after 3rd-degree burns, etc. If you are interested, please write
3
Q.
Are you seeking development of a product/technology, or primarily a research collaboration? Would this be more as a CRO-style engagement, where we run assays on a fee-for-service basis, or more collaborative?
MW
Maggie Waldron, Corporate Relations, Northwestern University
April 8, 2026
3
A.
Thank you, we are primarily looking for a CRO-style engagement, but certainly open to some degree of collaboration!
Team Member, Reviewer, Private Company
April 14, 2026
Is this response helpful?
1
0
Q.
We have in vivo models. Is this of value to validate the HTP in vitro system?
2
A.
thank you, but we cannot do any work with animals!
Team Member, Reviewer, Private Company
April 14, 2026
Is this response helpful?
0
0
Q.
Hello we are currently exploring bamboo derived biopolymers (hydrogels) as mediums for both wound healing and tissue/cell regeneration. Would this be of interest to you?
1
Sign up to access the full partnering request.
View the details of this request and connect directly with corporate R&D teams at Fortune 500 companies.
Share partnering request
Complete
Refine recommendations
Is this request relevant to you?
Eligible partners
Academic researchersStartupsSuppliersService providers (CROs/CMOs)Consultants
Seeking partners focused on
Cell BiologyCell Membrane TransportPharmacologyRegenerative MedicineCell TherapyBiotechnology

Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.